Dermata Therapeutics, Inc. (DRMA)
NCM · Healthcare · Biotechnology
$1.18
-3.28%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$4.7M
Shares Outstanding
4.0M
Exchange
NCM
Currency
USD
About Dermata Therapeutics, Inc.
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -1.8M | -1.8M | -1.9M | -1.9M |
| Net Income | -1.7M | -1.7M | -1.9M | -1.8M |
| Diluted EPS | $-1.66 | $-1.65 | $nan | $-0.48 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -9.7M | -8.0M | -12.5M | -7.8M |
| Net Income | -9.6M | -7.8M | -12.3M | -7.6M |
| Diluted EPS | $-2,088.00 | $-399.90 | $-80.32 | $-8.16 |